Home › Funds › AIGH Capital Management LLC › KYTX
AIGH Capital Management LLC position in KYTX
KYVERNA THERAPEUTICS INC · Health Care
AIGH Capital Management LLC reported holding 3,650,000 shares of KYTX (KYVERNA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$24.8M, representing 2.50% of its reported portfolio and ranking #14 among its reported holdings. AIGH Capital Management LLC has disclosed KYTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How AIGH Capital Management LLC's KYTX position evolved
AIGH Capital Management LLC first disclosed a stake in KYTX in Q4 2025 at 1,500,000 shares (US$14.1M). The position peaked in Q2 2026 at 2,795,797 shares, worth US$24.9M. Across 4 filings, AIGH Capital Management LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,650,000 shares valued at US$24.8M — an increase of 854,203 shares quarter over quarter.. Notable position changes include a 33% increase in Q1 2026 (shares rose 3% over the following quarter), a 40% increase in Q2 2026 (shares fell 24% over the following quarter), a 31% increase in Q3 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.50M | $14.10M | New |
| Q1 2026 | 2.00M | $17.26M | Add |
| Q2 2026 | 2.80M | $24.91M | Add |
| Q3 2026 | 3.65M | $24.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYTX and 13F data
KYTX (KYVERNA THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in KYTX — the largest reported positions include GordonMD Global Investments LP (US$37.8M), GILEAD SCIENCES, INC. (US$28.1M), Bain Capital Life Sciences Investors, LLC (US$25.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYTX
- GordonMD Global Investments LP 4.24M sh · $37.82M · Q2 2026
- GILEAD SCIENCES, INC. 4.13M sh · $28.06M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 2.88M sh · $25.71M · Q2 2026
- Insight Holdings Group, LLC 989.05K sh · $8.81M · Q2 2026
- MBB PUBLIC MARKETS I LLC 614.48K sh · $5.47M · Q2 2026
- Propel Bio Management, LLC 700.60K sh · $4.76M · Q3 2026
More on AIGH Capital Management LLC
FAQ
How long has AIGH Capital Management LLC held KYTX?
AIGH Capital Management LLC has disclosed KYTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is AIGH Capital Management LLC's current position in KYTX?
As of Q3 2026, AIGH Capital Management LLC holds 3.65M shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $24.82M, representing 2.50% of its reported portfolio and ranking #14.
Has AIGH Capital Management LLC been buying or selling KYTX?
In the latest 13F filing (Q3 2026), AIGH Capital Management LLC increased its position in KYTX. The position peaked in Q2 2026 at 2.80M shares.
Which other funds hold KYTX?
Other major institutional holders of KYTX include GordonMD Global Investments LP, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.